Major ophthalmic events in the first quarter of 2026 included treatments for presbyopia, age-related macular degeneration ...

Manage worsening presbyopia effectively by prioritizing annual eye exams and high-quality reading glasses. Addressing ...

Please provide your email address to receive an email when new articles are posted on . The first FDA-approved presbyopia-correcting IOL entered the U.S. market in 1997 when the Allergan Medical ...

Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced that the U.S. Food and Drug ...

Please provide your email address to receive an email when new articles are posted on . Presbyopia is a very common age-related process that negatively impacts visual performance and quality of life.

With best-in-class image contrast and low-light performance, TECNIS Odyssey IOL expands the Johnson & Johnson portfolio of ...

The first FDA-approved eye drops to treat age-related blurry near vision (presbyopia) has gone on sale in the US, offering a potential alternative to reading glasses for the estimated 128 million ...

- Presbyopia, or age-related blurry near vision, is a common, progressive condition that reduces the eye's ability to focus on near objects and affects nearly half of the U.S. adult population, ...

SAN DIEGO -- A low-dose formulation of pilocarpine significantly improved visual acuity in presbyopia without adversely affecting distance vision, results of two randomized trials showed. As compared ...

"Presbyopia Pipeline"Major companies actively shaping the presbyopia treatment landscape include Glaukos Corporation, Orasis Pharmaceuticals, Novartis, Cellix Bio, Visus Therapeutics, AbbVie, Vyluma, ...